Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

TOI Oncology Institute Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TOI

Price (delayed)

$2.44

Market cap

$217.73M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$53,005

Enterprise value

$280.3M

Highlights
The EPS has grown by 22% YoY
TOI's revenue is up by 18% year-on-year and by 2.5% since the previous quarter
TOI's equity has dropped by 88% year-on-year but it is up by 41% since the previous quarter
The gross margin has contracted by 13% YoY but it has grown by 7% from the previous quarter
The quick ratio has contracted by 45% YoY and by 20% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities

Key stats

What are the main financial stats of TOI
Market
Shares outstanding
89.23M
Market cap
$217.73M
Enterprise value
$280.3M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
36.46
Price to sales (P/S)
0.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.7
Earnings
Revenue
$403.15M
Gross profit
$59.28M
Operating income
-$52.06M
Net income
-$64.36M
EBIT
-$53.28M
EBITDA
-$46.7M
Free cash flow
-$19.15M
Per share
EPS
-$53,005
EPS diluted
-$53,005
Free cash flow per share
-$0.25
Book value per share
$0.07
Revenue per share
$5.23
TBVPS
$1.85
Balance sheet
Total assets
$164M
Total liabilities
$158.93M
Debt
$102.31M
Equity
$5.07M
Working capital
$47.28M
Liquidity
Debt to equity
20.18
Current ratio
1.79
Quick ratio
1.5
Net debt/EBITDA
-1.34
Margins
EBITDA margin
-11.6%
Gross margin
14.7%
Net margin
-16%
Operating margin
-12.9%
Efficiency
Return on assets
-37%
Return on equity
-482.6%
Return on invested capital
-30.1%
Return on capital employed
-51%
Return on sales
-13.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TOI stock price

How has the Oncology Institute stock price performed over time
Intraday
-1.21%
1 week
-6.15%
1 month
-18.39%
1 year
442.22%
YTD
689.64%
QTD
114.04%

Financial performance

How have Oncology Institute's revenue and profit performed over time
Revenue
$403.15M
Gross profit
$59.28M
Operating income
-$52.06M
Net income
-$64.36M
Gross margin
14.7%
Net margin
-16%
Oncology Institute's operating margin has increased by 29% YoY and by 16% from the previous quarter
The company's net margin rose by 25% YoY and by 2.4% QoQ
TOI's revenue is up by 18% year-on-year and by 2.5% since the previous quarter
The operating income rose by 16% year-on-year and by 13% since the previous quarter

Price vs fundamentals

How does TOI's price correlate with its fundamentals

Growth

What is Oncology Institute's growth rate over time

Valuation

What is Oncology Institute stock price valuation
TOI P/E details
P/E
N/A
P/B
36.46
P/S
0.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.7
The EPS has grown by 22% YoY
TOI's equity has dropped by 88% year-on-year but it is up by 41% since the previous quarter
The P/S is 64% less than the 5-year quarterly average of 1.3
TOI's revenue is up by 18% year-on-year and by 2.5% since the previous quarter

Efficiency

How efficient is Oncology Institute business performance
The company's return on equity has shrunk by 67% QoQ
The ROS has grown by 31% YoY and by 9% from the previous quarter
The company's return on invested capital fell by 10% YoY and by 2.7% QoQ
The ROA is down by 9% year-on-year and by 5% since the previous quarter

Dividends

What is TOI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TOI.

Financial health

How did Oncology Institute financials performed over time
The total assets is 3.2% more than the total liabilities
The quick ratio has contracted by 45% YoY and by 20% from the previous quarter
The current ratio has contracted by 42% YoY and by 17% from the previous quarter
TOI's equity has dropped by 88% year-on-year but it is up by 41% since the previous quarter
The debt to equity has contracted by 41% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.